Discontinued — last reported Q4 '26
Non-Marketable Equity Securities Impairment
Semtech Non-Marketable Equity Securities Impairment remained flat by 0.0% to $2.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 28752.8%, from $9.00K to $2.60M. Over 4 years (FY 2022 to FY 2026), Non-Marketable Equity Securities Impairment shows an upward trend with a 67.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase signals poor performance or valuation declines in the company's strategic investment portfolio.
Detailed definition
This represents the write-down of the value of equity investments that do not have a readily determinable fair value. It...
Peer comparison
Common for companies with venture-style investment arms; peers with similar portfolios report these as market conditions shift.
c_non_marketable_equity_securities_impairmentHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $334.25K | $334.25K | $334.25K | $334.25K | $289.00K | $289.00K | $289.00K | $289.00K | $982.25K | $982.25K | $982.25K | $2.33M | $277.25K | $277.25K | $277.25K | $9.00K | $2.60M | $2.60M | $2.60M | $2.60M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -13.5% | +0.0% | +0.0% | +0.0% | +239.9% | +0.0% | +0.0% | +137.1% | -88.1% | +0.0% | +0.0% | -96.8% | >999% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -13.5% | -13.5% | -13.5% | -13.5% | +239.9% | +239.9% | +239.9% | +705.9% | -71.8% | -71.8% | -71.8% | -99.6% | +836.6% | +836.6% | +836.6% | >999% |
Non-Marketable Equity Securities Impairment at Other Companies
Frequently Asked Questions
- What is Semtech's non-marketable equity securities impairment?
- Semtech (SMTC) reported non-marketable equity securities impairment of $2.60M in Q4 2025.
- How has Semtech's non-marketable equity securities impairment changed year-over-year?
- Semtech's non-marketable equity securities impairment increased by 28752.8% year-over-year, from $9.00K to $2.60M.
- What is the long-term trend for Semtech's non-marketable equity securities impairment?
- Over 4 years (2022 to 2026), Semtech's non-marketable equity securities impairment has grown at a 67.0% compound annual growth rate (CAGR), from $1.34M to $10.39M.
- What does non-marketable equity securities impairment mean?
- Losses from the decline in value of private or non-traded investments.